Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
AVTR vs DHR
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Diagnostics & Research
AVTR vs DHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Diagnostics & Research |
| Market Cap | $5.76B | $123.80B |
| Revenue (TTM) | $6.55B | $24.78B |
| Net Income (TTM) | $-551M | $3.69B |
| Gross Margin | 32.1% | 60.7% |
| Operating Margin | -4.3% | 21.0% |
| Forward P/E | 10.7x | 20.7x |
| Total Debt | $3.95B | $18.42B |
| Cash & Equiv. | $365M | $4.62B |
AVTR vs DHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Avantor, Inc. (AVTR) | 100 | 44.4 | -55.6% |
| Danaher Corporation (DHR) | 100 | 118.4 | +18.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVTR vs DHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVTR is the clearest fit if your priority is value.
- Lower P/E (10.7x vs 20.7x)
DHR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.94, yield 0.7%
- Rev growth 2.9%, EPS growth -4.7%, 3Y rev CAGR -2.7%
- 218.0% 10Y total return vs AVTR's -41.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.9% revenue growth vs AVTR's -3.4% | |
| Value | Lower P/E (10.7x vs 20.7x) | |
| Quality / Margins | 14.9% margin vs AVTR's -8.4% | |
| Stability / Safety | Beta 0.94 vs AVTR's 1.54, lower leverage | |
| Dividends | 0.7% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -7.2% vs AVTR's -29.6% | |
| Efficiency (ROA) | 4.5% ROA vs AVTR's -4.6%, ROIC 5.9% vs -2.0% |
AVTR vs DHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AVTR vs DHR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DHR leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DHR is the larger business by revenue, generating $24.8B annually — 3.8x AVTR's $6.6B. DHR is the more profitable business, keeping 14.9% of every revenue dollar as net income compared to AVTR's -8.4%. On growth, DHR holds the edge at +3.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $6.6B | $24.8B |
| EBITDAEarnings before interest/tax | $137M | $7.2B |
| Net IncomeAfter-tax profit | -$551M | $3.7B |
| Free Cash FlowCash after capex | $439M | $5.3B |
| Gross MarginGross profit ÷ Revenue | +32.1% | +60.7% |
| Operating MarginEBIT ÷ Revenue | -4.3% | +21.0% |
| Net MarginNet income ÷ Revenue | -8.4% | +14.9% |
| FCF MarginFCF ÷ Revenue | +6.7% | +21.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | 0.0% | +3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -32.6% | +9.8% |
Valuation Metrics
AVTR leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, DHR's 18.1x EV/EBITDA is more attractive than AVTR's 56.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $5.8B | $123.8B |
| Enterprise ValueMkt cap + debt − cash | $9.3B | $137.6B |
| Trailing P/EPrice ÷ TTM EPS | -10.81x | 34.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.73x | 20.73x |
| PEG RatioP/E ÷ EPS growth rate | — | 34.20x |
| EV / EBITDAEnterprise value multiple | 56.93x | 18.14x |
| Price / SalesMarket cap ÷ Revenue | 0.88x | 5.04x |
| Price / BookPrice ÷ Book value/share | 1.03x | 2.37x |
| Price / FCFMarket cap ÷ FCF | 11.63x | 23.54x |
Profitability & Efficiency
DHR leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
DHR delivers a 7.1% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-10 for AVTR. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVTR's 0.71x. On the Piotroski fundamental quality scale (0–9), DHR scores 7/9 vs AVTR's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -9.6% | +7.1% |
| ROA (TTM)Return on assets | -4.6% | +4.5% |
| ROICReturn on invested capital | -2.0% | +5.9% |
| ROCEReturn on capital employed | -2.4% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.71x | 0.35x |
| Net DebtTotal debt minus cash | $3.6B | $13.8B |
| Cash & Equiv.Liquid assets | $365M | $4.6B |
| Total DebtShort + long-term debt | $3.9B | $18.4B |
| Interest CoverageEBIT ÷ Interest expense | -1.55x | 18.13x |
Total Returns (Dividends Reinvested)
DHR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DHR five years ago would be worth $7,907 today (with dividends reinvested), compared to $2,718 for AVTR. Over the past 12 months, DHR leads with a -7.2% total return vs AVTR's -29.6%. The 3-year compound annual growth rate (CAGR) favors DHR at -5.6% vs AVTR's -25.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -26.4% | -23.9% |
| 1-Year ReturnPast 12 months | -29.6% | -7.2% |
| 3-Year ReturnCumulative with dividends | -58.0% | -15.9% |
| 5-Year ReturnCumulative with dividends | -72.8% | -20.9% |
| 10-Year ReturnCumulative with dividends | -41.9% | +218.0% |
| CAGR (3Y)Annualised 3-year return | -25.1% | -5.6% |
Risk & Volatility
DHR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DHR is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than AVTR's 1.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DHR currently trades 72.0% from its 52-week high vs AVTR's 52.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.54x | 0.94x |
| 52-Week HighHighest price in past year | $15.93 | $242.80 |
| 52-Week LowLowest price in past year | $7.26 | $172.06 |
| % of 52W HighCurrent price vs 52-week peak | +52.9% | +72.0% |
| RSI (14)Momentum oscillator 0–100 | 48.7 | 32.3 |
| Avg Volume (50D)Average daily shares traded | 8.8M | 4.1M |
Analyst Outlook
DHR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates AVTR as "Hold" and DHR as "Buy". Consensus price targets imply 41.2% upside for DHR (target: $247) vs 12.7% for AVTR (target: $10). DHR is the only dividend payer here at 0.71% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $9.50 | $247.00 |
| # AnalystsCovering analysts | 26 | 42 |
| Dividend YieldAnnual dividend ÷ price | — | +0.7% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +2.5% |
DHR leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AVTR leads in 1 (Valuation Metrics).
AVTR vs DHR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AVTR or DHR a better buy right now?
For growth investors, Danaher Corporation (DHR) is the stronger pick with 2.
9% revenue growth year-over-year, versus -3. 4% for Avantor, Inc. (AVTR). Danaher Corporation (DHR) offers the better valuation at 34. 7x trailing P/E (20. 7x forward), making it the more compelling value choice. Analysts rate Danaher Corporation (DHR) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVTR or DHR?
On forward P/E, Avantor, Inc.
is actually cheaper at 10. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AVTR or DHR?
Over the past 5 years, Danaher Corporation (DHR) delivered a total return of -20.
9%, compared to -72. 8% for Avantor, Inc. (AVTR). Over 10 years, the gap is even starker: DHR returned +218. 0% versus AVTR's -41. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVTR or DHR?
By beta (market sensitivity over 5 years), Danaher Corporation (DHR) is the lower-risk stock at 0.
94β versus Avantor, Inc. 's 1. 54β — meaning AVTR is approximately 64% more volatile than DHR relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 71% for Avantor, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AVTR or DHR?
By revenue growth (latest reported year), Danaher Corporation (DHR) is pulling ahead at 2.
9% versus -3. 4% for Avantor, Inc. (AVTR). On earnings-per-share growth, the picture is similar: Danaher Corporation grew EPS -4. 7% year-over-year, compared to -175. 0% for Avantor, Inc.. Over a 3-year CAGR, DHR leads at -2. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVTR or DHR?
Danaher Corporation (DHR) is the more profitable company, earning 14.
7% net margin versus -8. 1% for Avantor, Inc. — meaning it keeps 14. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DHR leads at 20. 9% versus -3. 8% for AVTR. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVTR or DHR more undervalued right now?
On forward earnings alone, Avantor, Inc.
(AVTR) trades at 10. 7x forward P/E versus 20. 7x for Danaher Corporation — 10. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 41. 2% to $247. 00.
08Which pays a better dividend — AVTR or DHR?
In this comparison, DHR (0.
7% yield) pays a dividend. AVTR does not pay a meaningful dividend and should not be held primarily for income.
09Is AVTR or DHR better for a retirement portfolio?
For long-horizon retirement investors, Danaher Corporation (DHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
94), 0. 7% yield, +218. 0% 10Y return). Avantor, Inc. (AVTR) carries a higher beta of 1. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DHR: +218. 0%, AVTR: -41. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVTR and DHR?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
DHR pays a dividend while AVTR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.